STANKOVICH THOMAS 4
4 · ReShape Lifesciences Inc. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
STANKOVICH THOMAS
Chief Financial Officer
Transactions
- Sale
Common Stock, $0.001 par value per share
2022-12-01$0.15/sh−5,144$778→ 327,617 total - Award
Common Stock, $0.001 par value per share
2022-11-17+364,756→ 697,517 total - Sale
Common Stock, $0.001 par value per share
2022-11-28$0.17/sh−364,756$61,826→ 332,761 total - Sale
Common Stock, $0.001 par value per share
2022-12-01$0.15/sh−2,213$334→ 325,404 total
Footnotes (3)
- [F1]These shares were issued pursuant to a stock bonus granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
- [F2]These shares were sold to cover taxes and fees in connection with the stock bonus.
- [F3]On July 22, 2021, Mr. Stankovich was awarded an aggregate of 372,744 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.